The prevalence and risk factors for new-onset interstitial lung disease (ILD) among previously ILD-negative systemic sclerosis patients are reported in new research presented at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting.
New research shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35 per cent of patients and is asymptomatic in one-third.